Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial

Journal:
Nature Medicine
Published:
Affiliations:
19
Authors:
22
Institutions Authors Share
Netherlands Cancer Institute (NKI), Netherlands
9.866667
0.45
Natera, United States of America (USA)
4.000000
0.18
Foundation Dutch Uro-Oncology Study group (DUOS), Netherlands
3.033333
0.14
University Medical Center Utrecht (UMC Utrecht), Netherlands
2.000000
0.09
Erasmus MC Cancer Institute, Netherlands
1.000000
0.05
Erasmus University Medical Center (Erasmus MC), Netherlands
1.000000
0.05
Oncode Institute, Netherlands
0.500000
0.02
Caritas-Krankenhaus St. Josef, Germany
0.200000
0.01
University of Regensburg (UR), Germany
0.200000
0.01
Leiden University Medical Center (LUMC), Netherlands
0.200000
0.01